News & Blog

Jumpstarting Brain Tumor Drug Development

National Brain Tumor Society staff and advisors recently met with the U.S. Food and Drug Administration (FDA) to discuss how various stakeholders in brain tumor drug development could work together to increase the volume and speed of approvals for new treatments for this disease.

National Brain Tumor Society’s First Community Research Fund

The National Brain Tumor Society and OligoNation announced Dr. David Louis, MD, of Massachusetts General Hospital and Harvard Medical School, and Dr. Anders Persson, PhD, of The University of California, San Francisco as the first grant recipients of the Oligodendroglioma Research Fund.

Head to the Hill Advocacy Day Draws Hundreds to Capitol Hill

Brain tumor advocates in Washington, D.C. speak up for the vital needs of the brain tumor community at the National Brain Tumor Society’s annual event.

Share